Study,Study Country,Study Site,Subject,Event Group Label,Event Group Name,Event Group Sequence Number,Event Label,Event Name,Event Date,Form Casebook Version,Form Label,Form Name,Form Sequence Number,Form Status,Datetime of Form Creation,Form First Submission Date,Form Last Submission Date,Form ILB Status,Form ILB Reason,Item Group Sequence Number,Datetime of Last Data Change,Data Listing As Of,Opened Queries,Closed Queries,Start date & time (ig_EC_1.ECSTDTC_RANGE_1),Start date & time (ig_EC_1.ECSTDTC_RANGE_1)_UTC,Start date & time (ig_EC_1.ECSTDTC_RANGE_1)_USER,Start date & time (ig_EC_1.ECSTDTC_RANGE_1)_RAW,End date & time (ig_EC_1.ECENDTC_1),End date & time (ig_EC_1.ECENDTC_1)_UTC,End date & time (ig_EC_1.ECENDTC_1)_USER,End date & time (ig_EC_1.ECENDTC_1)_RAW,Planned Dose [for this visit] (ig_EC_1.ECDSTXT1_1),Planned Dose Unit (ig_EC_1.ECDOSU1_1), Actual dose administered at this visit (ig_EC_1.ECDSTXT_1),Actual Unit (ig_EC_1.ECDOSU_1),Route (ig_EC_1.ECROUTE_1),Frequency (ig_EC_1.ECDOSFRQ_1),"If dose adjusted, reason (ig_EC_1.ECADJ_1)",Form SDV Status,Form SDV Datetime,Form DMR Status,Form DMR Datetime,Form Frozen Status,Form Frozen Datetime,Form Locked Status,Form Locked Datetime,Form Signed Status,Form Signed Datetime
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 1,ev_DAY1,2016-05-19,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 08:18:24 UTC,,2024-11-19 08:20:57 UTC,false,,1,2024-11-19 08:20:05 UTC,2025-08-19 10:50:09 UTC,2,0,2026-03-03 14:18:00 EST,2026-03-03 19:18:00 UTC,2026-03-03 19:18:00 GMT,03-Mar-2026 14:18,2026-03-08 14:18:00 EDT,2026-03-08 18:18:00 UTC,2026-03-08 18:18:00 GMT,08-Mar-2026 14:18,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 1,ev_DAY1,2016-05-19,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 08:18:02 UTC,,2024-11-19 08:20:13 UTC,false,,1,2024-11-19 08:18:43 UTC,2025-08-19 10:50:09 UTC,2,1,2026-01-22 14:18:00 EST,2026-01-22 19:18:00 UTC,2026-01-22 19:18:00 GMT,22-Jan-2026 14:18,2026-01-27 14:18:00 EST,2026-01-27 19:18:00 UTC,2026-01-27 19:18:00 GMT,27-Jan-2026 14:18,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 1,ev_DAY1,2016-05-19,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 08:18:06 UTC,,2024-11-19 08:20:25 UTC,false,,1,2024-11-19 08:19:06 UTC,2025-08-19 10:50:09 UTC,2,1,2026-02-01 14:18:00 EST,2026-02-01 19:18:00 UTC,2026-02-01 19:18:00 GMT,01-Feb-2026 14:18,2026-02-06 14:18:00 EST,2026-02-06 19:18:00 UTC,2026-02-06 19:18:00 GMT,06-Feb-2026 14:18,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 1,ev_DAY1,2016-09-08,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 10:47:40 UTC,,2024-11-19 10:50:33 UTC,false,,1,2024-11-19 10:48:32 UTC,2025-08-19 10:50:09 UTC,2,0,2031-08-04 16:47:00 EDT,2031-08-04 20:47:00 UTC,2031-08-04 20:47:00 GMT,04-Aug-2031 16:47,2031-08-09 16:47:00 EDT,2031-08-09 20:47:00 UTC,2031-08-09 20:47:00 GMT,09-Aug-2031 16:47,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 1,ev_DAY1,2016-05-19,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 08:18:12 UTC,,2024-11-19 08:20:35 UTC,false,,1,2024-11-19 08:19:28 UTC,2025-08-19 10:50:09 UTC,2,1,2026-02-11 14:18:00 EST,2026-02-11 19:18:00 UTC,2026-02-11 19:18:00 GMT,11-Feb-2026 14:18,2026-02-16 14:18:00 EST,2026-02-16 19:18:00 UTC,2026-02-16 19:18:00 GMT,16-Feb-2026 14:18,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 1,ev_DAY1,2016-09-08,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 10:47:47 UTC,,2024-11-19 10:50:49 UTC,false,,1,2024-11-19 10:49:00 UTC,2025-08-19 10:50:09 UTC,2,1,2031-08-14 16:47:00 EDT,2031-08-14 20:47:00 UTC,2031-08-14 20:47:00 GMT,14-Aug-2031 16:47,2031-08-19 16:47:00 EDT,2031-08-19 20:47:00 UTC,2031-08-19 20:47:00 GMT,19-Aug-2031 16:47,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 1,ev_DAY1,2016-05-19,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 08:18:17 UTC,,2024-11-19 08:20:46 UTC,false,,1,2024-11-19 08:19:46 UTC,2025-08-19 10:50:09 UTC,2,1,2026-02-21 14:18:00 EST,2026-02-21 19:18:00 UTC,2026-02-21 19:18:00 GMT,21-Feb-2026 14:18,2026-02-26 14:18:00 EST,2026-02-26 19:18:00 UTC,2026-02-26 19:18:00 GMT,26-Feb-2026 14:18,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 1,ev_DAY1,2016-09-08,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 10:47:53 UTC,,2024-11-19 10:51:04 UTC,false,,1,2024-11-19 10:49:29 UTC,2025-08-19 10:50:09 UTC,2,0,2031-08-24 16:47:00 EDT,2031-08-24 20:47:00 UTC,2031-08-24 20:47:00 GMT,24-Aug-2031 16:47,2031-08-29 16:47:00 EDT,2031-08-29 20:47:00 UTC,2031-08-29 20:47:00 GMT,29-Aug-2031 16:47,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 1,ev_DAY1,2016-09-08,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 10:47:59 UTC,,2024-11-19 10:51:18 UTC,false,,1,2024-11-19 10:49:57 UTC,2025-08-19 10:50:09 UTC,2,1,2031-09-03 16:48:00 EDT,2031-09-03 20:48:00 UTC,2031-09-03 20:48:00 GMT,03-Sep-2031 16:48,2031-09-08 16:48:00 EDT,2031-09-08 20:48:00 UTC,2031-09-08 20:48:00 GMT,08-Sep-2031 16:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 1,ev_DAY1,2016-09-08,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 10:48:06 UTC,,2024-11-19 10:51:33 UTC,false,,1,2024-11-19 10:50:24 UTC,2025-08-19 10:50:09 UTC,2,1,2031-09-13 16:48:00 EDT,2031-09-13 20:48:00 UTC,2031-09-13 20:48:00 GMT,13-Sep-2031 16:48,2031-09-18 16:48:00 EDT,2031-09-18 20:48:00 UTC,2031-09-18 20:48:00 GMT,18-Sep-2031 16:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0357,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2025-05-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 15:41:23 UTC,,2025-05-05 15:41:43 UTC,false,,1,2025-05-05 15:41:42 UTC,2025-08-19 10:50:09 UTC,3,0,2025-04-04 11:11:00 EDT,2025-04-04 15:11:00 UTC,2025-04-04 15:11:00 GMT,04-Apr-2025 11:11,2025-04-03 11:11:00 EDT,2025-04-03 15:11:00 UTC,2025-04-03 15:11:00 GMT,03-Apr-2025 11:11,500,mg,5,mg,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0462,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-01-10,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 12:25:21 UTC,,2025-05-05 12:25:45 UTC,false,,1,2025-05-05 12:25:44 UTC,2025-08-19 10:50:09 UTC,0,0,2024-01-10 12:12:00 EST,2024-01-10 17:12:00 UTC,2024-01-10 17:12:00 GMT,10-Jan-2024 12:12,2024-01-10 12:12:00 EST,2024-01-10 17:12:00 UTC,2024-01-10 17:12:00 GMT,10-Jan-2024 12:12,500,mg,1,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 1,ev_DAY1,2016-06-16,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 08:51:22 UTC,,2024-11-19 08:54:08 UTC,false,,1,2024-11-19 08:53:17 UTC,2025-08-19 10:50:09 UTC,2,0,2027-07-21 14:51:00 EDT,2027-07-21 18:51:00 UTC,2027-07-21 18:51:00 GMT,21-Jul-2027 14:51,2027-07-26 14:51:00 EDT,2027-07-26 18:51:00 UTC,2027-07-26 18:51:00 GMT,26-Jul-2027 14:51,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 1,ev_DAY1,2016-06-16,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 08:51:15 UTC,,2024-11-19 08:53:57 UTC,false,,1,2024-11-19 08:52:55 UTC,2025-08-19 10:50:09 UTC,2,1,2027-07-11 14:51:00 EDT,2027-07-11 18:51:00 UTC,2027-07-11 18:51:00 GMT,11-Jul-2027 14:51,2027-07-16 14:51:00 EDT,2027-07-16 18:51:00 UTC,2027-07-16 18:51:00 GMT,16-Jul-2027 14:51,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 1,ev_DAY1,2016-06-16,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 08:51:09 UTC,,2024-11-19 08:53:46 UTC,false,,1,2024-11-19 08:52:33 UTC,2025-08-19 10:50:09 UTC,2,1,2027-07-01 14:51:00 EDT,2027-07-01 18:51:00 UTC,2027-07-01 18:51:00 GMT,01-Jul-2027 14:51,2027-07-06 14:51:00 EDT,2027-07-06 18:51:00 UTC,2027-07-06 18:51:00 GMT,06-Jul-2027 14:51,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 1,ev_DAY1,2016-06-16,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 08:51:02 UTC,,2024-11-19 08:53:37 UTC,false,,1,2024-11-19 08:52:08 UTC,2025-08-19 10:50:09 UTC,2,0,2027-06-21 14:51:00 EDT,2027-06-21 18:51:00 UTC,2027-06-21 18:51:00 GMT,21-Jun-2027 14:51,2027-06-26 14:51:00 EDT,2027-06-26 18:51:00 UTC,2027-06-26 18:51:00 GMT,26-Jun-2027 14:51,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 1,ev_DAY1,2016-06-16,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 08:50:55 UTC,,2024-11-19 08:53:26 UTC,false,,1,2024-11-19 08:51:45 UTC,2025-08-19 10:50:09 UTC,2,0,2027-06-11 14:50:00 EDT,2027-06-11 18:50:00 UTC,2027-06-11 18:50:00 GMT,11-Jun-2027 14:50,2027-06-16 14:50:00 EDT,2027-06-16 18:50:00 UTC,2027-06-16 18:50:00 GMT,16-Jun-2027 14:50,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0464,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-01-10,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 12:26:47 UTC,,2025-05-05 12:27:02 UTC,false,,1,2025-05-05 12:27:01 UTC,2025-08-19 10:50:09 UTC,2,0,,,,,,,,,500,mg,1,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0463,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-01-10,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 12:26:07 UTC,,2025-05-05 12:26:30 UTC,false,,1,2025-05-05 12:26:30 UTC,2025-08-19 10:50:09 UTC,0,0,2024-01-11 12:12:00 EST,2024-01-11 17:12:00 UTC,2024-01-11 17:12:00 GMT,11-Jan-2024 12:12,2024-01-11 12:12:00 EST,2024-01-11 17:12:00 UTC,2024-01-11 17:12:00 GMT,11-Jan-2024 12:12,500,mg,1,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 1,ev_DAY1,2016-07-14,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 09:27:08 UTC,,2024-11-19 09:29:50 UTC,false,,1,2024-11-19 09:28:30 UTC,2025-08-19 10:50:09 UTC,2,1,2028-11-17 15:27:00 EST,2028-11-17 20:27:00 UTC,2028-11-17 20:27:00 GMT,17-Nov-2028 15:27,2028-11-22 15:27:00 EST,2028-11-22 20:27:00 UTC,2028-11-22 20:27:00 GMT,22-Nov-2028 15:27,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 1,ev_DAY1,2016-07-14,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 09:27:14 UTC,,2024-11-19 09:30:03 UTC,false,,1,2024-11-19 09:28:53 UTC,2025-08-19 10:50:09 UTC,2,0,2028-11-27 15:27:00 EST,2028-11-27 20:27:00 UTC,2028-11-27 20:27:00 GMT,27-Nov-2028 15:27,2028-12-02 15:27:00 EST,2028-12-02 20:27:00 UTC,2028-12-02 20:27:00 GMT,02-Dec-2028 15:27,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0025,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2023-03-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-11 10:15:15 UTC,,2024-11-11 10:15:24 UTC,false,,1,2024-11-11 10:15:24 UTC,2025-08-19 10:50:09 UTC,6,0,2023-03-06 11:00:00 EST,2023-03-06 16:00:00 UTC,2023-03-06 16:00:00 GMT,06-Mar-2023 11:00,2023-03-07 11:00:00 EST,2023-03-07 16:00:00 UTC,2023-03-07 16:00:00 GMT,07-Mar-2023 11:00,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0340,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2024-03-20,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 16:29:34 UTC,,2025-02-13 16:30:05 UTC,false,,1,2025-02-13 16:30:02 UTC,2025-08-19 10:50:09 UTC,2,0,2024-03-20 10:00:00 EDT,2024-03-20 14:00:00 UTC,2024-03-20 14:00:00 GMT,20-Mar-2024 10:00,2024-03-20 12:00:00 EDT,2024-03-20 16:00:00 UTC,2024-03-20 16:00:00 GMT,20-Mar-2024 12:00,,,23,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0452,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-05 10:05:16 UTC,,2025-05-05 10:05:35 UTC,false,,1,2025-05-05 10:05:35 UTC,2025-08-19 10:50:09 UTC,0,0,2025-05-02 12:00:00 EDT,2025-05-02 16:00:00 UTC,2025-05-02 16:00:00 GMT,02-May-2025 12:00,2025-05-03 13:00:00 EDT,2025-05-03 17:00:00 UTC,2025-05-03 17:00:00 GMT,03-May-2025 13:00,500,mg,100,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 15,ev_DAY15,2016-08-04,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 09:48:08 UTC,,2024-11-19 09:51:05 UTC,false,,1,2024-11-19 09:49:54 UTC,2025-08-19 10:50:09 UTC,2,1,2029-08-09 15:48:00 EDT,2029-08-09 19:48:00 UTC,2029-08-09 19:48:00 GMT,09-Aug-2029 15:48,2029-08-14 15:48:00 EDT,2029-08-14 19:48:00 UTC,2029-08-14 19:48:00 GMT,14-Aug-2029 15:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2016-01-28,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 06:39:26 UTC,,2024-11-19 06:40:19 UTC,false,,1,2024-11-19 06:39:57 UTC,2025-08-19 10:50:09 UTC,0,1,2020-08-01 12:39:00 EDT,2020-08-01 16:39:00 UTC,2020-08-01 16:39:00 GMT,01-Aug-2020 12:39,2020-08-06 12:39:00 EDT,2020-08-06 16:39:00 UTC,2020-08-06 16:39:00 GMT,06-Aug-2020 12:39,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 1,ev_DAY1,2016-04-21,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 07:48:41 UTC,,2024-11-19 07:50:36 UTC,false,,1,2024-11-19 07:49:50 UTC,2025-08-19 10:50:09 UTC,0,1,2024-10-04 13:48:00 EDT,2024-10-04 17:48:00 UTC,2024-10-04 17:48:00 GMT,04-Oct-2024 13:48,2024-10-09 13:48:00 EDT,2024-10-09 17:48:00 UTC,2024-10-09 17:48:00 GMT,09-Oct-2024 13:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2016-01-28,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 06:39:20 UTC,,2024-11-19 06:40:17 UTC,false,,1,2024-11-19 06:39:50 UTC,2025-08-19 10:50:09 UTC,0,0,2020-07-22 12:39:00 EDT,2020-07-22 16:39:00 UTC,2020-07-22 16:39:00 GMT,22-Jul-2020 12:39,2020-07-27 12:39:00 EDT,2020-07-27 16:39:00 UTC,2020-07-27 16:39:00 GMT,27-Jul-2020 12:39,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 15,ev_DAY15,2016-03-17,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 07:12:35 UTC,,2024-11-19 07:14:11 UTC,false,,1,2024-11-19 07:13:46 UTC,2025-08-19 10:50:09 UTC,0,0,2022-09-20 13:12:00 EDT,2022-09-20 17:12:00 UTC,2022-09-20 17:12:00 GMT,20-Sep-2022 13:12,2022-09-25 13:12:00 EDT,2022-09-25 17:12:00 UTC,2022-09-25 17:12:00 GMT,25-Sep-2022 13:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 1,ev_DAY1,2016-04-21,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 07:48:36 UTC,,2024-11-19 07:50:28 UTC,false,,1,2024-11-19 07:49:34 UTC,2025-08-19 10:50:09 UTC,0,1,2024-09-24 13:48:00 EDT,2024-09-24 17:48:00 UTC,2024-09-24 17:48:00 GMT,24-Sep-2024 13:48,2024-09-29 13:48:00 EDT,2024-09-29 17:48:00 UTC,2024-09-29 17:48:00 GMT,29-Sep-2024 13:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2016-01-28,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 06:39:16 UTC,,2024-11-19 06:40:13 UTC,false,,1,2024-11-19 06:39:42 UTC,2025-08-19 10:50:09 UTC,0,1,2020-07-12 12:39:00 EDT,2020-07-12 16:39:00 UTC,2020-07-12 16:39:00 GMT,12-Jul-2020 12:39,2020-07-17 12:39:00 EDT,2020-07-17 16:39:00 UTC,2020-07-17 16:39:00 GMT,17-Jul-2020 12:39,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 15,ev_DAY15,2016-03-17,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 07:12:31 UTC,,2024-11-19 07:14:06 UTC,false,,1,2024-11-19 07:13:32 UTC,2025-08-19 10:50:09 UTC,0,0,2022-09-10 13:12:00 EDT,2022-09-10 17:12:00 UTC,2022-09-10 17:12:00 GMT,10-Sep-2022 13:12,2022-09-15 13:12:00 EDT,2022-09-15 17:12:00 UTC,2022-09-15 17:12:00 GMT,15-Sep-2022 13:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 1,ev_DAY1,2016-04-21,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 07:48:32 UTC,,2024-11-19 07:50:22 UTC,false,,1,2024-11-19 07:49:19 UTC,2025-08-19 10:50:09 UTC,0,0,2024-09-14 13:48:00 EDT,2024-09-14 17:48:00 UTC,2024-09-14 17:48:00 GMT,14-Sep-2024 13:48,2024-09-19 13:48:00 EDT,2024-09-19 17:48:00 UTC,2024-09-19 17:48:00 GMT,19-Sep-2024 13:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 15,ev_DAY15,2016-03-17,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 07:12:26 UTC,,2024-11-19 07:14:01 UTC,false,,1,2024-11-19 07:13:19 UTC,2025-08-19 10:50:09 UTC,0,0,2022-08-31 13:12:00 EDT,2022-08-31 17:12:00 UTC,2022-08-31 17:12:00 GMT,31-Aug-2022 13:12,2022-09-05 13:12:00 EDT,2022-09-05 17:12:00 UTC,2022-09-05 17:12:00 GMT,05-Sep-2022 13:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 1,ev_DAY1,2016-04-21,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 07:48:28 UTC,,2024-11-19 07:50:13 UTC,false,,1,2024-11-19 07:49:02 UTC,2025-08-19 10:50:09 UTC,0,1,2024-09-04 13:48:00 EDT,2024-09-04 17:48:00 UTC,2024-09-04 17:48:00 GMT,04-Sep-2024 13:48,2024-09-09 13:48:00 EDT,2024-09-09 17:48:00 UTC,2024-09-09 17:48:00 GMT,09-Sep-2024 13:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2016-01-28,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 06:39:33 UTC,,2024-11-19 06:40:26 UTC,false,,1,2024-11-19 06:40:10 UTC,2025-08-19 10:50:09 UTC,0,0,2020-08-21 12:39:00 EDT,2020-08-21 16:39:00 UTC,2020-08-21 16:39:00 GMT,21-Aug-2020 12:39,2020-08-26 12:39:00 EDT,2020-08-26 16:39:00 UTC,2020-08-26 16:39:00 GMT,26-Aug-2020 12:39,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 1,ev_DAY1,2016-01-28,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 06:39:30 UTC,,2024-11-19 06:40:23 UTC,false,,1,2024-11-19 06:40:03 UTC,2025-08-19 10:50:09 UTC,0,0,2020-08-11 12:39:00 EDT,2020-08-11 16:39:00 UTC,2020-08-11 16:39:00 GMT,11-Aug-2020 12:39,2020-08-16 12:39:00 EDT,2020-08-16 16:39:00 UTC,2020-08-16 16:39:00 GMT,16-Aug-2020 12:39,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 1,ev_DAY1,2016-04-21,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 07:48:46 UTC,,2024-11-19 07:50:44 UTC,false,,1,2024-11-19 07:50:06 UTC,2025-08-19 10:50:09 UTC,0,1,2024-10-14 13:48:00 EDT,2024-10-14 17:48:00 UTC,2024-10-14 17:48:00 GMT,14-Oct-2024 13:48,2024-10-19 13:48:00 EDT,2024-10-19 17:48:00 UTC,2024-10-19 17:48:00 GMT,19-Oct-2024 13:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 15,ev_DAY15,2016-08-04,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 09:47:50 UTC,,2024-11-19 09:50:27 UTC,false,,1,2024-11-19 09:48:38 UTC,2025-08-19 10:50:09 UTC,2,0,2029-07-10 15:47:00 EDT,2029-07-10 19:47:00 UTC,2029-07-10 19:47:00 GMT,10-Jul-2029 15:47,2029-07-15 15:47:00 EDT,2029-07-15 19:47:00 UTC,2029-07-15 19:47:00 GMT,15-Jul-2029 15:47,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 15,ev_DAY15,2016-08-04,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 09:47:57 UTC,,2024-11-19 09:50:40 UTC,false,,1,2024-11-19 09:49:03 UTC,2025-08-19 10:50:09 UTC,2,0,2029-07-20 15:47:00 EDT,2029-07-20 19:47:00 UTC,2029-07-20 19:47:00 GMT,20-Jul-2029 15:47,2029-07-25 15:47:00 EDT,2029-07-25 19:47:00 UTC,2029-07-25 19:47:00 GMT,25-Jul-2029 15:47,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 15,ev_DAY15,2016-08-04,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 09:48:03 UTC,,2024-11-19 09:50:52 UTC,false,,1,2024-11-19 09:49:29 UTC,2025-08-19 10:50:09 UTC,2,1,2029-07-30 15:48:00 EDT,2029-07-30 19:48:00 UTC,2029-07-30 19:48:00 GMT,30-Jul-2029 15:48,2029-08-04 15:48:00 EDT,2029-08-04 19:48:00 UTC,2029-08-04 19:48:00 GMT,04-Aug-2029 15:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 15,ev_DAY15,2016-03-17,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 07:12:21 UTC,,2024-11-19 07:13:57 UTC,false,,1,2024-11-19 07:13:05 UTC,2025-08-19 10:50:09 UTC,0,0,2022-08-21 13:12:00 EDT,2022-08-21 17:12:00 UTC,2022-08-21 17:12:00 GMT,21-Aug-2022 13:12,2022-08-26 13:12:00 EDT,2022-08-26 17:12:00 UTC,2022-08-26 17:12:00 GMT,26-Aug-2022 13:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0346,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-02-13,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 17:08:59 UTC,,2025-02-13 17:09:30 UTC,false,,1,2025-02-13 17:09:28 UTC,2025-08-19 10:50:09 UTC,0,0,2024-02-13 10:00:00 EST,2024-02-13 15:00:00 UTC,2024-02-13 15:00:00 GMT,13-Feb-2024 10:00,2024-02-13 12:00:00 EST,2024-02-13 17:00:00 UTC,2024-02-13 17:00:00 GMT,13-Feb-2024 12:00,500,mg,120,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 15,ev_DAY15,2016-03-17,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 07:12:16 UTC,,2024-11-19 07:13:51 UTC,false,,1,2024-11-19 07:12:50 UTC,2025-08-19 10:50:09 UTC,0,0,2022-08-11 13:12:00 EDT,2022-08-11 17:12:00 UTC,2022-08-11 17:12:00 GMT,11-Aug-2022 13:12,2022-08-16 13:12:00 EDT,2022-08-16 17:12:00 UTC,2022-08-16 17:12:00 GMT,16-Aug-2022 13:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0035,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-03,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-12-12 06:28:28 UTC,,2024-12-12 06:28:56 UTC,false,,1,2024-12-12 06:28:55 UTC,2025-08-19 10:50:09 UTC,0,0,2024-11-03 11:11:00 EST,2024-11-03 16:11:00 UTC,2024-11-03 16:11:00 GMT,03-Nov-2024 11:11,2024-11-04 11:11:00 EST,2024-11-04 16:11:00 UTC,2024-11-04 16:11:00 GMT,04-Nov-2024 11:11,500,mg,122,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 1,ev_DAY1,2016-07-14,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 09:26:56 UTC,,2024-11-19 09:29:24 UTC,false,,1,2024-11-19 09:27:43 UTC,2025-08-19 10:50:09 UTC,2,1,2028-10-28 15:26:00 EDT,2028-10-28 19:26:00 UTC,2028-10-28 19:26:00 GMT,28-Oct-2028 15:26,2028-11-02 15:26:00 EDT,2028-11-02 19:26:00 UTC,2028-11-02 19:26:00 GMT,02-Nov-2028 15:26,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 1,ev_DAY1,2016-07-14,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 09:27:02 UTC,,2024-11-19 09:29:38 UTC,false,,1,2024-11-19 09:28:07 UTC,2025-08-19 10:50:09 UTC,2,1,2028-11-07 15:27:00 EST,2028-11-07 20:27:00 UTC,2028-11-07 20:27:00 GMT,07-Nov-2028 15:27,2028-11-12 15:27:00 EST,2028-11-12 20:27:00 UTC,2028-11-12 20:27:00 GMT,12-Nov-2028 15:27,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 15,ev_DAY15,2016-09-01,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 10:28:31 UTC,,2024-11-19 10:31:20 UTC,false,,1,2024-11-19 10:29:40 UTC,2025-08-19 10:50:09 UTC,2,0,2030-12-07 16:28:00 EST,2030-12-07 21:28:00 UTC,2030-12-07 21:28:00 GMT,07-Dec-2030 16:28,2030-12-12 16:28:00 EST,2030-12-12 21:28:00 UTC,2030-12-12 21:28:00 GMT,12-Dec-2030 16:28,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 15,ev_DAY15,2016-07-07,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 09:10:01 UTC,,2024-11-19 09:12:52 UTC,false,,1,2024-11-19 09:11:47 UTC,2025-08-19 10:50:09 UTC,2,1,2028-03-22 15:10:00 EDT,2028-03-22 19:10:00 UTC,2028-03-22 19:10:00 GMT,22-Mar-2028 15:10,2028-03-27 15:10:00 EDT,2028-03-27 19:10:00 UTC,2028-03-27 19:10:00 GMT,27-Mar-2028 15:10,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 15,ev_DAY15,2016-09-01,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 10:28:37 UTC,,2024-11-19 10:31:33 UTC,false,,1,2024-11-19 10:30:06 UTC,2025-08-19 10:50:09 UTC,2,0,2030-12-17 16:28:00 EST,2030-12-17 21:28:00 UTC,2030-12-17 21:28:00 GMT,17-Dec-2030 16:28,2030-12-22 16:28:00 EST,2030-12-22 21:28:00 UTC,2030-12-22 21:28:00 GMT,22-Dec-2030 16:28,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 15,ev_DAY15,2016-07-07,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 09:09:55 UTC,,2024-11-19 09:12:42 UTC,false,,1,2024-11-19 09:11:26 UTC,2025-08-19 10:50:09 UTC,2,0,2028-03-12 15:09:00 EDT,2028-03-12 19:09:00 UTC,2028-03-12 19:09:00 GMT,12-Mar-2028 15:09,2028-03-17 15:09:00 EDT,2028-03-17 19:09:00 UTC,2028-03-17 19:09:00 GMT,17-Mar-2028 15:09,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 15,ev_DAY15,2016-09-01,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 10:28:43 UTC,,2024-11-19 10:31:47 UTC,false,,1,2024-11-19 10:30:33 UTC,2025-08-19 10:50:09 UTC,2,0,2030-12-27 16:28:00 EST,2030-12-27 21:28:00 UTC,2030-12-27 21:28:00 GMT,27-Dec-2030 16:28,2031-01-01 16:28:00 EST,2031-01-01 21:28:00 UTC,2031-01-01 21:28:00 GMT,01-Jan-2031 16:28,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 15,ev_DAY15,2016-07-07,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 09:09:49 UTC,,2024-11-19 09:12:28 UTC,false,,1,2024-11-19 09:11:02 UTC,2025-08-19 10:50:09 UTC,2,1,2028-03-02 15:09:00 EST,2028-03-02 20:09:00 UTC,2028-03-02 20:09:00 GMT,02-Mar-2028 15:09,2028-03-07 15:09:00 EST,2028-03-07 20:09:00 UTC,2028-03-07 20:09:00 GMT,07-Mar-2028 15:09,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 15,ev_DAY15,2016-07-07,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 09:09:43 UTC,,2024-11-19 09:12:17 UTC,false,,1,2024-11-19 09:10:34 UTC,2025-08-19 10:50:09 UTC,2,0,2028-02-21 15:09:00 EST,2028-02-21 20:09:00 UTC,2028-02-21 20:09:00 GMT,21-Feb-2028 15:09,2028-02-26 15:09:00 EST,2028-02-26 20:09:00 UTC,2028-02-26 20:09:00 GMT,26-Feb-2028 15:09,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0340,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2024-04-02,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 16:41:22 UTC,,2025-02-13 16:41:59 UTC,false,,1,2025-02-13 16:41:59 UTC,2025-08-19 10:50:09 UTC,0,0,2024-04-02 10:00:00 EDT,2024-04-02 14:00:00 UTC,2024-04-02 14:00:00 GMT,02-Apr-2024 10:00,2024-04-02 12:00:00 EDT,2024-04-02 16:00:00 UTC,2024-04-02 16:00:00 GMT,02-Apr-2024 12:00,500,mg,89,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0356,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2025-05-01,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-05 15:40:46 UTC,,2025-05-05 15:41:09 UTC,false,,1,2025-05-05 15:41:08 UTC,2025-08-19 10:50:09 UTC,1,0,2025-04-03 11:11:00 EDT,2025-04-03 15:11:00 UTC,2025-04-03 15:11:00 GMT,03-Apr-2025 11:11,2025-04-04 11:11:00 EDT,2025-04-04 15:11:00 UTC,2025-04-04 15:11:00 GMT,04-Apr-2025 11:11,500,mg,4,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 15,ev_DAY15,2016-08-04,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 09:48:15 UTC,,2024-11-19 09:51:19 UTC,false,,1,2024-11-19 09:50:19 UTC,2025-08-19 10:50:09 UTC,2,0,2029-08-19 15:48:00 EDT,2029-08-19 19:48:00 UTC,2029-08-19 19:48:00 GMT,19-Aug-2029 15:48,2029-08-24 15:48:00 EDT,2029-08-24 19:48:00 UTC,2029-08-24 19:48:00 GMT,24-Aug-2029 15:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (9),eg_CYCLE,9,Day 1,ev_DAY1,2016-07-14,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 09:27:20 UTC,,2024-11-19 09:30:14 UTC,false,,1,2024-11-19 09:29:17 UTC,2025-08-19 10:50:09 UTC,2,0,2028-12-07 15:27:00 EST,2028-12-07 20:27:00 UTC,2028-12-07 20:27:00 GMT,07-Dec-2028 15:27,2028-12-12 15:27:00 EST,2028-12-12 20:27:00 UTC,2028-12-12 20:27:00 GMT,12-Dec-2028 15:27,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 15,ev_DAY15,2016-09-29,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 11:12:23 UTC,,2024-11-19 11:15:33 UTC,false,,1,2024-11-19 11:13:18 UTC,2025-08-19 10:50:09 UTC,2,0,2032-04-15 17:12:00 EDT,2032-04-15 21:12:00 UTC,2032-04-15 21:12:00 GMT,15-Apr-2032 17:12,2032-04-20 17:12:00 EDT,2032-04-20 21:12:00 UTC,2032-04-20 21:12:00 GMT,20-Apr-2032 17:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 15,ev_DAY15,2016-09-29,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 11:12:30 UTC,,2024-11-19 11:15:48 UTC,false,,1,2024-11-19 11:13:48 UTC,2025-08-19 10:50:09 UTC,2,1,2032-04-25 17:12:00 EDT,2032-04-25 21:12:00 UTC,2032-04-25 21:12:00 GMT,25-Apr-2032 17:12,2032-04-30 17:12:00 EDT,2032-04-30 21:12:00 UTC,2032-04-30 21:12:00 GMT,30-Apr-2032 17:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 15,ev_DAY15,2016-09-29,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 11:12:37 UTC,,2024-11-19 11:16:05 UTC,false,,1,2024-11-19 11:14:17 UTC,2025-08-19 10:50:09 UTC,2,0,2032-05-05 17:12:00 EDT,2032-05-05 21:12:00 UTC,2032-05-05 21:12:00 GMT,05-May-2032 17:12,2032-05-10 17:12:00 EDT,2032-05-10 21:12:00 UTC,2032-05-10 21:12:00 GMT,10-May-2032 17:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0035,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2020-11-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-11 11:06:33 UTC,,2024-11-11 11:07:08 UTC,false,,1,2024-11-11 11:07:07 UTC,2025-08-19 10:50:09 UTC,0,0,2020-11-05 12:00:00 EST,2020-11-05 17:00:00 UTC,2020-11-05 17:00:00 GMT,05-Nov-2020 12:00,2020-11-06 12:23:00 EST,2020-11-06 17:23:00 UTC,2020-11-06 17:23:00 GMT,06-Nov-2020 12:23,500,mg,90,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 15,ev_DAY15,2016-09-29,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 11:12:44 UTC,,2024-11-19 11:16:19 UTC,false,,1,2024-11-19 11:14:46 UTC,2025-08-19 10:50:09 UTC,2,0,2032-05-15 17:12:00 EDT,2032-05-15 21:12:00 UTC,2032-05-15 21:12:00 GMT,15-May-2032 17:12,2032-05-20 17:12:00 EDT,2032-05-20 21:12:00 UTC,2032-05-20 21:12:00 GMT,20-May-2032 17:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (11),eg_CYCLE,11,Day 15,ev_DAY15,2016-09-29,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 11:12:51 UTC,,2024-11-19 11:16:36 UTC,false,,1,2024-11-19 11:15:18 UTC,2025-08-19 10:50:09 UTC,2,1,2032-05-25 17:12:00 EDT,2032-05-25 21:12:00 UTC,2032-05-25 21:12:00 GMT,25-May-2032 17:12,2032-05-30 17:12:00 EDT,2032-05-30 21:12:00 UTC,2032-05-30 21:12:00 GMT,30-May-2032 17:12,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 15,ev_DAY15,2016-09-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 10:28:24 UTC,,2024-11-19 10:31:06 UTC,false,,1,2024-11-19 10:29:14 UTC,2025-08-19 10:50:09 UTC,2,0,2030-11-27 16:28:00 EST,2030-11-27 21:28:00 UTC,2030-11-27 21:28:00 GMT,27-Nov-2030 16:28,2030-12-02 16:28:00 EST,2030-12-02 21:28:00 UTC,2030-12-02 21:28:00 GMT,02-Dec-2030 16:28,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (8),eg_CYCLE,8,Day 15,ev_DAY15,2016-07-07,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 09:10:08 UTC,,2024-11-19 09:13:04 UTC,false,,1,2024-11-19 09:12:10 UTC,2025-08-19 10:50:09 UTC,2,0,2028-04-01 15:10:00 EDT,2028-04-01 19:10:00 UTC,2028-04-01 19:10:00 GMT,01-Apr-2028 15:10,2028-04-06 15:10:00 EDT,2028-04-06 19:10:00 UTC,2028-04-06 19:10:00 GMT,06-Apr-2028 15:10,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0345,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-02-07,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 17:02:17 UTC,,2025-02-13 17:02:48 UTC,false,,1,2025-02-13 17:02:47 UTC,2025-08-19 10:50:09 UTC,0,0,2024-02-07 10:00:00 EST,2024-02-07 15:00:00 UTC,2024-02-07 15:00:00 GMT,07-Feb-2024 10:00,2024-02-07 12:00:00 EST,2024-02-07 17:00:00 UTC,2024-02-07 17:00:00 GMT,07-Feb-2024 12:00,500,mg,100,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0340,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2024-03-27,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 16:34:07 UTC,,2025-02-13 16:34:44 UTC,false,,1,2025-02-13 16:34:43 UTC,2025-08-19 10:50:09 UTC,2,0,2024-03-27 10:00:00 EDT,2024-03-27 14:00:00 UTC,2024-03-27 14:00:00 GMT,27-Mar-2024 10:00,2024-03-27 12:00:00 EDT,2024-03-27 16:00:00 UTC,2024-03-27 16:00:00 GMT,27-Mar-2024 12:00,,,45,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0110,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-03,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-12-26 06:45:52 UTC,,2024-12-26 06:46:09 UTC,false,,1,2024-12-26 06:46:08 UTC,2025-08-19 10:50:09 UTC,1,0,2024-12-01 11:11:00 EST,2024-12-01 16:11:00 UTC,2024-12-01 16:11:00 GMT,01-Dec-2024 11:11,2024-12-02 11:11:00 EST,2024-12-02 16:11:00 UTC,2024-12-02 16:11:00 GMT,02-Dec-2024 11:11,500,mg,11,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0067,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2020-01-15,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-15 08:31:50 UTC,,2024-11-15 08:32:08 UTC,false,,1,2024-11-15 08:32:07 UTC,2025-08-19 10:50:09 UTC,6,2,2020-01-26 09:00:00 EST,2020-01-26 14:00:00 UTC,2020-01-26 14:00:00 GMT,26-Jan-2020 09:00,2020-01-26 09:30:00 EST,2020-01-26 14:30:00 UTC,2020-01-26 14:30:00 GMT,26-Jan-2020 09:30,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 15,ev_DAY15,2016-09-01,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 10:28:49 UTC,,2024-11-19 10:32:00 UTC,false,,1,2024-11-19 10:30:59 UTC,2025-08-19 10:50:09 UTC,2,1,2031-01-06 16:28:00 EST,2031-01-06 21:28:00 UTC,2031-01-06 21:28:00 GMT,06-Jan-2031 16:28,2031-01-11 16:28:00 EST,2031-01-11 21:28:00 UTC,2031-01-11 21:28:00 GMT,11-Jan-2031 16:28,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0415,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 09:54:36 UTC,,2025-05-05 13:27:19 UTC,false,,1,2025-05-05 09:55:11 UTC,2025-08-19 10:50:09 UTC,2,0,2025-05-01 09:00:00 EDT,2025-05-01 13:00:00 UTC,2025-05-01 13:00:00 GMT,01-May-2025 09:00,2025-05-01 08:00:00 EDT,2025-05-01 12:00:00 UTC,2025-05-01 12:00:00 GMT,01-May-2025 08:00,500,mg,250,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0336,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-01-03,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-01-06 11:47:11 UTC,,2025-01-06 11:47:41 UTC,false,,1,2025-01-06 11:47:40 UTC,2025-08-19 10:50:09 UTC,0,0,2025-01-01 12:00:00 EST,2025-01-01 17:00:00 UTC,2025-01-01 17:00:00 GMT,01-Jan-2025 12:00,2025-01-01 16:00:00 EST,2025-01-01 21:00:00 UTC,2025-01-01 21:00:00 GMT,01-Jan-2025 16:00,500,mg,300,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0095,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2023-03-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-28 11:09:56 UTC,,2024-11-28 11:10:02 UTC,false,,1,2024-11-28 11:10:01 UTC,2025-08-19 10:50:09 UTC,6,2,2023-03-06 11:00:00 EST,2023-03-06 16:00:00 UTC,2023-03-06 16:00:00 GMT,06-Mar-2023 11:00,2023-03-07 11:00:00 EST,2023-03-07 16:00:00 UTC,2023-03-07 16:00:00 GMT,07-Mar-2023 11:00,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0454,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 10:14:30 UTC,,2025-05-06 07:03:27 UTC,false,,1,2025-05-06 07:03:27 UTC,2025-08-19 10:50:09 UTC,1,0,2025-05-01 10:00:00 EDT,2025-05-01 14:00:00 UTC,2025-05-01 14:00:00 GMT,01-May-2025 10:00,2025-05-01 10:00:00 EDT,2025-05-01 14:00:00 UTC,2025-05-01 14:00:00 GMT,01-May-2025 10:00,500,mg,300,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0051,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-01-02 11:59:40 UTC,,2025-01-02 12:03:03 UTC,false,,1,2025-01-02 12:03:02 UTC,2025-08-19 10:50:09 UTC,0,1,2024-12-05 11:11:00 EST,2024-12-05 16:11:00 UTC,2024-12-05 16:11:00 GMT,05-Dec-2024 11:11,2024-12-05 11:12:00 EST,2024-12-05 16:12:00 UTC,2024-12-05 16:12:00 GMT,05-Dec-2024 11:12,500,mg,123,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0036,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-03,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-12-12 06:31:58 UTC,,2024-12-12 06:32:25 UTC,false,,1,2024-12-12 06:32:24 UTC,2025-08-19 10:50:09 UTC,1,0,2024-12-07 11:11:00 EST,2024-12-07 16:11:00 UTC,2024-12-07 16:11:00 GMT,07-Dec-2024 11:11,2024-12-08 11:11:00 EST,2024-12-08 16:11:00 UTC,2024-12-08 16:11:00 GMT,08-Dec-2024 11:11,500,mg,11,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2016-02-25,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 06:58:01 UTC,,2024-11-19 06:59:39 UTC,false,,1,2024-11-19 06:58:44 UTC,2025-08-19 10:50:09 UTC,0,1,2021-11-29 12:58:00 EST,2021-11-29 17:58:00 UTC,2021-11-29 17:58:00 GMT,29-Nov-2021 12:58,2021-12-04 12:58:00 EST,2021-12-04 17:58:00 UTC,2021-12-04 17:58:00 GMT,04-Dec-2021 12:58,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0452,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 10:04:13 UTC,,2025-05-06 07:00:32 UTC,false,,1,2025-05-06 07:00:31 UTC,2025-08-19 10:50:09 UTC,0,2,2025-05-01 10:00:00 EDT,2025-05-01 14:00:00 UTC,2025-05-01 14:00:00 GMT,01-May-2025 10:00,2025-05-05 10:00:00 EDT,2025-05-05 14:00:00 UTC,2025-05-05 14:00:00 GMT,05-May-2025 10:00,500,mg,100,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0008,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2023-11-06,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-11 07:14:52 UTC,,2024-11-12 06:39:03 UTC,false,,1,2024-11-12 06:39:02 UTC,2025-08-19 10:50:09 UTC,7,2,2024-07-04 12:00:00 EDT,2024-07-04 16:00:00 UTC,2024-07-04 16:00:00 GMT,04-Jul-2024 12:00,2024-07-05 12:00:00 EDT,2024-07-05 16:00:00 UTC,2024-07-05 16:00:00 GMT,05-Jul-2024 12:00,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2016-02-25,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 06:58:08 UTC,,2024-11-19 06:59:45 UTC,false,,1,2024-11-19 06:58:56 UTC,2025-08-19 10:50:09 UTC,0,1,2021-12-09 12:58:00 EST,2021-12-09 17:58:00 UTC,2021-12-09 17:58:00 GMT,09-Dec-2021 12:58,2021-12-14 12:58:00 EST,2021-12-14 17:58:00 UTC,2021-12-14 17:58:00 GMT,14-Dec-2021 12:58,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 15,ev_DAY15,2016-05-12,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 08:03:15 UTC,,2024-11-19 08:05:29 UTC,false,,1,2024-11-19 08:04:34 UTC,2025-08-19 10:50:09 UTC,2,0,2025-06-16 14:03:00 EDT,2025-06-16 18:03:00 UTC,2025-06-16 18:03:00 GMT,16-Jun-2025 14:03,2025-06-21 14:03:00 EDT,2025-06-21 18:03:00 UTC,2025-06-21 18:03:00 GMT,21-Jun-2025 14:03,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 15,ev_DAY15,2016-05-12,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 08:03:09 UTC,,2024-11-19 08:05:19 UTC,false,,1,2024-11-19 08:04:15 UTC,2025-08-19 10:50:09 UTC,2,1,2025-06-06 14:03:00 EDT,2025-06-06 18:03:00 UTC,2025-06-06 18:03:00 GMT,06-Jun-2025 14:03,2025-06-11 14:03:00 EDT,2025-06-11 18:03:00 UTC,2025-06-11 18:03:00 GMT,11-Jun-2025 14:03,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 15,ev_DAY15,2016-05-12,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 08:03:03 UTC,,2024-11-19 08:05:11 UTC,false,,1,2024-11-19 08:03:56 UTC,2025-08-19 10:50:09 UTC,2,0,2025-05-27 14:03:00 EDT,2025-05-27 18:03:00 UTC,2025-05-27 18:03:00 GMT,27-May-2025 14:03,2025-06-01 14:03:00 EDT,2025-06-01 18:03:00 UTC,2025-06-01 18:03:00 GMT,01-Jun-2025 14:03,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 15,ev_DAY15,2016-05-12,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 08:02:57 UTC,,2024-11-19 08:05:02 UTC,false,,1,2024-11-19 08:03:37 UTC,2025-08-19 10:50:09 UTC,2,0,2025-05-17 14:02:00 EDT,2025-05-17 18:02:00 UTC,2025-05-17 18:02:00 GMT,17-May-2025 14:02,2025-05-22 14:02:00 EDT,2025-05-22 18:02:00 UTC,2025-05-22 18:02:00 GMT,22-May-2025 14:02,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2016-02-25,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 06:58:26 UTC,,2024-11-19 07:00:02 UTC,false,,1,2024-11-19 06:59:33 UTC,2025-08-19 10:50:09 UTC,0,0,2022-01-08 12:58:00 EST,2022-01-08 17:58:00 UTC,2022-01-08 17:58:00 GMT,08-Jan-2022 12:58,2022-01-13 12:58:00 EST,2022-01-13 17:58:00 UTC,2022-01-13 17:58:00 GMT,13-Jan-2022 12:58,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 15,ev_DAY15,2016-02-18,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 06:48:34 UTC,,2024-11-19 06:50:15 UTC,false,,1,2024-11-19 06:49:24 UTC,2025-08-19 10:50:09 UTC,0,1,2021-04-03 12:48:00 EDT,2021-04-03 16:48:00 UTC,2021-04-03 16:48:00 GMT,03-Apr-2021 12:48,2021-04-08 12:48:00 EDT,2021-04-08 16:48:00 UTC,2021-04-08 16:48:00 GMT,08-Apr-2021 12:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2016-02-25,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 06:58:21 UTC,,2024-11-19 06:59:56 UTC,false,,1,2024-11-19 06:59:21 UTC,2025-08-19 10:50:10 UTC,0,1,2021-12-29 12:58:00 EST,2021-12-29 17:58:00 UTC,2021-12-29 17:58:00 GMT,29-Dec-2021 12:58,2022-01-03 12:58:00 EST,2022-01-03 17:58:00 UTC,2022-01-03 17:58:00 GMT,03-Jan-2022 12:58,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 15,ev_DAY15,2016-02-18,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 06:48:28 UTC,,2024-11-19 06:50:10 UTC,false,,1,2024-11-19 06:49:12 UTC,2025-08-19 10:50:10 UTC,0,0,2021-03-24 12:48:00 EDT,2021-03-24 16:48:00 UTC,2021-03-24 16:48:00 GMT,24-Mar-2021 12:48,2021-03-29 12:48:00 EDT,2021-03-29 16:48:00 UTC,2021-03-29 16:48:00 GMT,29-Mar-2021 12:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (4),eg_CYCLE,4,Day 1,ev_DAY1,2016-02-25,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 06:58:14 UTC,,2024-11-19 06:59:51 UTC,false,,1,2024-11-19 06:59:09 UTC,2025-08-19 10:50:10 UTC,0,1,2021-12-19 12:58:00 EST,2021-12-19 17:58:00 UTC,2021-12-19 17:58:00 GMT,19-Dec-2021 12:58,2021-12-24 12:58:00 EST,2021-12-24 17:58:00 UTC,2021-12-24 17:58:00 GMT,24-Dec-2021 12:58,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (6),eg_CYCLE,6,Day 15,ev_DAY15,2016-05-12,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 08:03:20 UTC,,2024-11-19 08:05:37 UTC,false,,1,2024-11-19 08:04:53 UTC,2025-08-19 10:50:10 UTC,2,0,2025-06-26 14:03:00 EDT,2025-06-26 18:03:00 UTC,2025-06-26 18:03:00 GMT,26-Jun-2025 14:03,2025-07-01 14:03:00 EDT,2025-07-01 18:03:00 UTC,2025-07-01 18:03:00 GMT,01-Jul-2025 14:03,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2016-03-24,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 07:23:40 UTC,,2024-11-19 07:25:15 UTC,false,,1,2024-11-19 07:24:18 UTC,2025-08-19 10:50:10 UTC,0,0,2023-04-18 13:23:00 EDT,2023-04-18 17:23:00 UTC,2023-04-18 17:23:00 GMT,18-Apr-2023 13:23,2023-04-23 13:23:00 EDT,2023-04-23 17:23:00 UTC,2023-04-23 17:23:00 GMT,23-Apr-2023 13:23,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2016-03-24,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 07:24:03 UTC,,2024-11-19 07:25:38 UTC,false,,1,2024-11-19 07:25:11 UTC,2025-08-19 10:50:10 UTC,0,1,2023-05-28 13:24:00 EDT,2023-05-28 17:24:00 UTC,2023-05-28 17:24:00 GMT,28-May-2023 13:24,2023-06-02 13:24:00 EDT,2023-06-02 17:24:00 UTC,2023-06-02 17:24:00 GMT,02-Jun-2023 13:24,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2016-03-24,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 07:23:57 UTC,,2024-11-19 07:25:32 UTC,false,,1,2024-11-19 07:24:57 UTC,2025-08-19 10:50:10 UTC,0,1,2023-05-18 13:23:00 EDT,2023-05-18 17:23:00 UTC,2023-05-18 17:23:00 GMT,18-May-2023 13:23,2023-05-23 13:23:00 EDT,2023-05-23 17:23:00 UTC,2023-05-23 17:23:00 GMT,23-May-2023 13:23,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 15,ev_DAY15,2016-06-09,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 08:35:17 UTC,,2024-11-19 08:37:28 UTC,false,,1,2024-11-19 08:36:10 UTC,2025-08-19 10:50:10 UTC,2,0,2026-10-14 14:35:00 EDT,2026-10-14 18:35:00 UTC,2026-10-14 18:35:00 GMT,14-Oct-2026 14:35,2026-10-19 14:35:00 EDT,2026-10-19 18:35:00 UTC,2026-10-19 18:35:00 GMT,19-Oct-2026 14:35,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2016-03-24,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 07:23:52 UTC,,2024-11-19 07:25:27 UTC,false,,1,2024-11-19 07:24:43 UTC,2025-08-19 10:50:10 UTC,0,0,2023-05-08 13:23:00 EDT,2023-05-08 17:23:00 UTC,2023-05-08 17:23:00 GMT,08-May-2023 13:23,2023-05-13 13:23:00 EDT,2023-05-13 17:23:00 UTC,2023-05-13 17:23:00 GMT,13-May-2023 13:23,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 15,ev_DAY15,2016-06-09,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 08:35:11 UTC,,2024-11-19 08:37:16 UTC,false,,1,2024-11-19 08:35:50 UTC,2025-08-19 10:50:10 UTC,2,1,2026-10-04 14:35:00 EDT,2026-10-04 18:35:00 UTC,2026-10-04 18:35:00 GMT,04-Oct-2026 14:35,2026-10-09 14:35:00 EDT,2026-10-09 18:35:00 UTC,2026-10-09 18:35:00 GMT,09-Oct-2026 14:35,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0023,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2023-11-05,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-11 12:28:53 UTC,,2024-11-11 12:29:35 UTC,false,,1,2024-11-11 12:29:34 UTC,2025-08-19 10:50:10 UTC,6,0,2020-11-02 11:11:00 EST,2020-11-02 16:11:00 UTC,2020-11-02 16:11:00 GMT,02-Nov-2020 11:11,2020-11-02 11:20:00 EST,2020-11-02 16:20:00 UTC,2020-11-02 16:20:00 GMT,02-Nov-2020 11:20,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 1,ev_DAY1,2016-03-24,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 07:23:46 UTC,,2024-11-19 07:25:21 UTC,false,,1,2024-11-19 07:24:31 UTC,2025-08-19 10:50:10 UTC,0,1,2023-04-28 13:23:00 EDT,2023-04-28 17:23:00 UTC,2023-04-28 17:23:00 GMT,28-Apr-2023 13:23,2023-05-03 13:23:00 EDT,2023-05-03 17:23:00 UTC,2023-05-03 17:23:00 GMT,03-May-2023 13:23,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0340,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-01-16,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 15:55:45 UTC,,2025-02-13 15:57:29 UTC,false,,1,2025-02-13 15:57:28 UTC,2025-08-19 10:50:10 UTC,0,0,2024-01-16 10:00:00 EST,2024-01-16 15:00:00 UTC,2024-01-16 15:00:00 GMT,16-Jan-2024 10:00,2024-01-16 12:00:00 EST,2024-01-16 17:00:00 UTC,2024-01-16 17:00:00 GMT,16-Jan-2024 12:00,500,mg,34,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0096,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-11-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Blank,2025-08-15 05:18:47 UTC,,,false,,1,,2025-08-19 10:50:10 UTC,0,0,,,,,,,,,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 15,ev_DAY15,2016-06-09,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 08:35:32 UTC,,2024-11-19 08:37:58 UTC,false,,1,2024-11-19 08:37:08 UTC,2025-08-19 10:50:10 UTC,2,1,2026-11-13 14:35:00 EST,2026-11-13 19:35:00 UTC,2026-11-13 19:35:00 GMT,13-Nov-2026 14:35,2026-11-18 14:35:00 EST,2026-11-18 19:35:00 UTC,2026-11-18 19:35:00 GMT,18-Nov-2026 14:35,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 15,ev_DAY15,2016-06-09,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 08:35:28 UTC,,2024-11-19 08:37:48 UTC,false,,1,2024-11-19 08:36:48 UTC,2025-08-19 10:50:10 UTC,2,1,2026-11-03 14:35:00 EST,2026-11-03 19:35:00 UTC,2026-11-03 19:35:00 GMT,03-Nov-2026 14:35,2026-11-08 14:35:00 EST,2026-11-08 19:35:00 UTC,2026-11-08 19:35:00 GMT,08-Nov-2026 14:35,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (7),eg_CYCLE,7,Day 15,ev_DAY15,2016-06-09,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 08:35:23 UTC,,2024-11-19 08:37:37 UTC,false,,1,2024-11-19 08:36:30 UTC,2025-08-19 10:50:10 UTC,2,1,2026-10-24 14:35:00 EDT,2026-10-24 18:35:00 UTC,2026-10-24 18:35:00 GMT,24-Oct-2026 14:35,2026-10-29 14:35:00 EDT,2026-10-29 18:35:00 UTC,2026-10-29 18:35:00 GMT,29-Oct-2026 14:35,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0006,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-11-15,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 06:21:49 UTC,,2024-11-19 06:22:17 UTC,false,,1,2024-11-19 06:22:14 UTC,2025-08-19 10:50:10 UTC,5,0,2024-11-01 11:23:00 EDT,2024-11-01 15:23:00 UTC,2024-11-01 15:23:00 GMT,01-Nov-2024 11:23,2024-11-18 15:45:00 EST,2024-11-18 20:45:00 UTC,2024-11-18 20:45:00 GMT,18-Nov-2024 15:45,,,,,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0005,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-11-16,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 06:19:52 UTC,,2024-11-19 06:20:49 UTC,false,,1,2024-11-19 06:20:48 UTC,2025-08-19 10:50:10 UTC,1,0,2024-08-07 10:34:00 EDT,2024-08-07 14:34:00 UTC,2024-08-07 14:34:00 GMT,07-Aug-2024 10:34,2024-10-30 13:45:00 EDT,2024-10-30 17:45:00 UTC,2024-10-30 17:45:00 GMT,30-Oct-2024 13:45,500,mg,450,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0340,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2024-02-29,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-02-13 16:22:04 UTC,,2025-02-13 16:22:44 UTC,false,,1,2025-02-13 16:22:44 UTC,2025-08-19 10:50:10 UTC,1,0,2024-02-29 10:00:00 EST,2024-02-29 15:00:00 UTC,2024-02-29 15:00:00 GMT,29-Feb-2024 10:00,2024-02-29 12:00:00 EST,2024-02-29 17:00:00 UTC,2024-02-29 17:00:00 GMT,29-Feb-2024 12:00,,mg,98,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 15,ev_DAY15,2016-02-18,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 06:48:41 UTC,,2024-11-19 06:50:21 UTC,false,,1,2024-11-19 06:49:37 UTC,2025-08-19 10:50:10 UTC,0,0,2021-04-13 12:48:00 EDT,2021-04-13 16:48:00 UTC,2021-04-13 16:48:00 GMT,13-Apr-2021 12:48,2021-04-18 12:48:00 EDT,2021-04-18 16:48:00 UTC,2021-04-18 16:48:00 GMT,18-Apr-2021 12:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0023,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2023-11-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-11 12:28:19 UTC,,2024-11-11 12:28:29 UTC,false,,1,2024-11-11 12:28:28 UTC,2025-08-19 10:50:10 UTC,6,0,2020-11-01 11:11:00 EST,2020-11-01 16:11:00 UTC,2020-11-01 16:11:00 GMT,01-Nov-2020 11:11,2020-11-01 11:15:00 EST,2020-11-01 16:15:00 UTC,2020-11-01 16:15:00 GMT,01-Nov-2020 11:15,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 15,ev_DAY15,2016-02-18,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 06:48:57 UTC,,2024-11-19 06:50:30 UTC,false,,1,2024-11-19 06:50:05 UTC,2025-08-19 10:50:10 UTC,0,0,2021-05-03 12:48:00 EDT,2021-05-03 16:48:00 UTC,2021-05-03 16:48:00 GMT,03-May-2021 12:48,2021-05-08 12:48:00 EDT,2021-05-08 16:48:00 UTC,2021-05-08 16:48:00 GMT,08-May-2021 12:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0026,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-01-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,In Edit,2024-11-11 08:04:55 UTC,,2024-11-11 08:04:57 UTC,false,,1,2024-11-11 08:12:39 UTC,2025-08-19 10:50:10 UTC,8,1,2024-01-03 10:10:00 EST,2024-01-03 15:10:00 UTC,2024-01-03 15:10:00 GMT,03-Jan-2024 10:10,2024-02-01 10:10:00 EST,2024-02-01 15:10:00 UTC,2024-02-01 15:10:00 GMT,01-Feb-2024 10:10,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (3),eg_CYCLE,3,Day 15,ev_DAY15,2016-02-18,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 06:48:50 UTC,,2024-11-19 06:50:24 UTC,false,,1,2024-11-19 06:49:51 UTC,2025-08-19 10:50:10 UTC,0,1,2021-04-23 12:48:00 EDT,2021-04-23 16:48:00 UTC,2021-04-23 16:48:00 GMT,23-Apr-2021 12:48,2021-04-28 12:48:00 EDT,2021-04-28 16:48:00 UTC,2021-04-28 16:48:00 GMT,28-Apr-2021 12:48,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0337,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-01-06 12:03:06 UTC,,2025-01-06 12:03:43 UTC,false,,1,2025-01-06 12:03:41 UTC,2025-08-19 10:50:10 UTC,0,0,2024-12-26 13:00:00 EST,2024-12-26 18:00:00 UTC,2024-12-26 18:00:00 GMT,26-Dec-2024 13:00,2024-12-28 14:00:00 EST,2024-12-28 19:00:00 UTC,2024-12-28 19:00:00 GMT,28-Dec-2024 14:00,500,mg,400,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0356,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2025-05-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 15:40:09 UTC,,2025-05-05 15:40:27 UTC,false,,1,2025-05-05 15:40:26 UTC,2025-08-19 10:50:10 UTC,1,0,2025-04-01 11:11:00 EDT,2025-04-01 15:11:00 UTC,2025-04-01 15:11:00 GMT,01-Apr-2025 11:11,2025-04-02 11:11:00 EDT,2025-04-02 15:11:00 UTC,2025-04-02 15:11:00 GMT,02-Apr-2025 11:11,500,mg,4,mg,Intravenous,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0472,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-05,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-05 13:17:12 UTC,,2025-05-06 07:11:57 UTC,false,,1,2025-05-06 07:11:56 UTC,2025-08-19 10:50:10 UTC,3,1,2025-05-03 08:00:00 EDT,2025-05-03 12:00:00 UTC,2025-05-03 12:00:00 GMT,03-May-2025 08:00,2025-05-04 09:00:00 EDT,2025-05-04 13:00:00 UTC,2025-05-04 13:00:00 GMT,04-May-2025 09:00,500,mg,,,Intravenous,,Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0064,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-10-09,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-14 18:16:30 UTC,,2024-11-14 18:17:07 UTC,false,,1,2024-11-14 18:17:06 UTC,2025-08-19 10:50:10 UTC,8,0,2024-10-16 03:35:00 EDT,2024-10-16 07:35:00 UTC,2024-10-16 07:35:00 GMT,16-Oct-2024 03:35,,,,,,,,,,,Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0357,Cycle (2),eg_CYCLE,2,Day 1,ev_DAY1,2025-05-01,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-05 15:42:00 UTC,,2025-05-05 15:42:23 UTC,false,,1,2025-05-05 15:42:22 UTC,2025-08-19 10:50:10 UTC,1,0,2025-04-02 11:11:00 EDT,2025-04-02 15:11:00 UTC,2025-04-02 15:11:00 GMT,02-Apr-2025 11:11,2025-04-01 11:11:00 EDT,2025-04-01 15:11:00 UTC,2025-04-01 15:11:00 GMT,01-Apr-2025 11:11,500,mg,4,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 15,ev_DAY15,2016-04-14,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 07:36:16 UTC,,2024-11-19 07:38:06 UTC,false,,1,2024-11-19 07:36:56 UTC,2025-08-19 10:50:10 UTC,0,1,2023-12-29 13:36:00 EST,2023-12-29 18:36:00 UTC,2023-12-29 18:36:00 GMT,29-Dec-2023 13:36,2024-01-03 13:36:00 EST,2024-01-03 18:36:00 UTC,2024-01-03 18:36:00 GMT,03-Jan-2024 13:36,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0075,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2020-10-30,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-15 11:03:08 UTC,,2024-11-15 11:03:09 UTC,false,,1,,2025-08-19 10:50:10 UTC,8,0,,,,,,,,,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 15,ev_DAY15,2016-04-14,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 07:36:39 UTC,,2024-11-19 07:38:36 UTC,false,,1,2024-11-19 07:37:59 UTC,2025-08-19 10:50:10 UTC,0,1,2024-02-07 13:36:00 EST,2024-02-07 18:36:00 UTC,2024-02-07 18:36:00 GMT,07-Feb-2024 13:36,2024-02-12 13:36:00 EST,2024-02-12 18:36:00 UTC,2024-02-12 18:36:00 GMT,12-Feb-2024 13:36,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 1,ev_DAY1,2016-08-11,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-19 10:06:34 UTC,,2024-11-19 10:09:14 UTC,false,,1,2024-11-19 10:07:24 UTC,2025-08-19 10:50:10 UTC,2,1,2030-03-17 16:06:00 EDT,2030-03-17 20:06:00 UTC,2030-03-17 20:06:00 GMT,17-Mar-2030 16:06,2030-03-22 16:06:00 EDT,2030-03-22 20:06:00 UTC,2030-03-22 20:06:00 GMT,22-Mar-2030 16:06,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 15,ev_DAY15,2016-04-14,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 07:36:33 UTC,,2024-11-19 07:38:29 UTC,false,,1,2024-11-19 07:37:42 UTC,2025-08-19 10:50:10 UTC,0,0,2024-01-28 13:36:00 EST,2024-01-28 18:36:00 UTC,2024-01-28 18:36:00 GMT,28-Jan-2024 13:36,2024-02-02 13:36:00 EST,2024-02-02 18:36:00 UTC,2024-02-02 18:36:00 GMT,02-Feb-2024 13:36,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 1,ev_DAY1,2016-08-11,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 10:06:41 UTC,,2024-11-19 10:09:29 UTC,false,,1,2024-11-19 10:07:49 UTC,2025-08-19 10:50:10 UTC,2,0,2030-03-27 16:06:00 EDT,2030-03-27 20:06:00 UTC,2030-03-27 20:06:00 GMT,27-Mar-2030 16:06,2030-04-01 16:06:00 EDT,2030-04-01 20:06:00 UTC,2030-04-01 20:06:00 GMT,01-Apr-2030 16:06,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 15,ev_DAY15,2016-04-14,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 07:36:28 UTC,,2024-11-19 07:38:21 UTC,false,,1,2024-11-19 07:37:25 UTC,2025-08-19 10:50:10 UTC,0,1,2024-01-18 13:36:00 EST,2024-01-18 18:36:00 UTC,2024-01-18 18:36:00 GMT,18-Jan-2024 13:36,2024-01-23 13:36:00 EST,2024-01-23 18:36:00 UTC,2024-01-23 18:36:00 GMT,23-Jan-2024 13:36,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 1,ev_DAY1,2016-08-11,1,Study Treatment Administration - Budigalimab,EC_F_1,3,Submitted,2024-11-19 10:06:47 UTC,,2024-11-19 10:09:41 UTC,false,,1,2024-11-19 10:08:16 UTC,2025-08-19 10:50:10 UTC,2,1,2030-04-06 16:06:00 EDT,2030-04-06 20:06:00 UTC,2030-04-06 20:06:00 GMT,06-Apr-2030 16:06,2030-04-11 16:06:00 EDT,2030-04-11 20:06:00 UTC,2030-04-11 20:06:00 GMT,11-Apr-2030 16:06,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (5),eg_CYCLE,5,Day 15,ev_DAY15,2016-04-14,1,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2024-11-19 07:36:22 UTC,,2024-11-19 07:38:14 UTC,false,,1,2024-11-19 07:37:10 UTC,2025-08-19 10:50:10 UTC,0,1,2024-01-08 13:36:00 EST,2024-01-08 18:36:00 UTC,2024-01-08 18:36:00 GMT,08-Jan-2024 13:36,2024-01-13 13:36:00 EST,2024-01-13 18:36:00 UTC,2024-01-13 18:36:00 GMT,13-Jan-2024 13:36,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 1,ev_DAY1,2016-08-11,1,Study Treatment Administration - Budigalimab,EC_F_1,4,Submitted,2024-11-19 10:06:52 UTC,,2024-11-19 10:09:54 UTC,false,,1,2024-11-19 10:08:41 UTC,2025-08-19 10:50:10 UTC,2,1,2030-04-16 16:06:00 EDT,2030-04-16 20:06:00 UTC,2030-04-16 20:06:00 GMT,16-Apr-2030 16:06,2030-04-21 16:06:00 EDT,2030-04-21 20:06:00 UTC,2030-04-21 20:06:00 GMT,21-Apr-2030 16:06,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0017,Cycle (10),eg_CYCLE,10,Day 1,ev_DAY1,2016-08-11,1,Study Treatment Administration - Budigalimab,EC_F_1,5,Submitted,2024-11-19 10:06:59 UTC,,2024-11-19 10:10:07 UTC,false,,1,2024-11-19 10:09:06 UTC,2025-08-19 10:50:10 UTC,2,1,2030-04-26 16:07:00 EDT,2030-04-26 20:07:00 UTC,2030-04-26 20:07:00 GMT,26-Apr-2030 16:07,2030-05-01 16:07:00 EDT,2030-05-01 20:07:00 UTC,2030-05-01 20:07:00 GMT,01-May-2030 16:07,500,mg,Actual do,mg,Intravenous,Q2W [Every Four weeks],Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0335,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-12-14,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-01-06 11:35:46 UTC,,2025-01-06 11:36:43 UTC,false,,1,2025-01-06 11:36:41 UTC,2025-08-19 10:50:10 UTC,0,0,2024-12-26 16:00:00 EST,2024-12-26 21:00:00 UTC,2024-12-26 21:00:00 GMT,26-Dec-2024 16:00,2024-12-26 18:00:00 EST,2024-12-26 23:00:00 UTC,2024-12-26 23:00:00 GMT,26-Dec-2024 18:00,500,mg,100,mg,Intravenous,Q2W [Every Four weeks],,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0009,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2024-02-01,1,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2024-11-11 08:57:18 UTC,,2024-11-12 09:51:17 UTC,false,,1,2024-11-12 09:51:15 UTC,2025-08-19 10:50:10 UTC,9,19,2024-11-01 23:45:00 EDT,2024-11-02 03:45:00 UTC,2024-11-02 03:45:00 GMT,01-Nov-2024 23:45,2024-11-01 23:46:00 EDT,2024-11-02 03:46:00 UTC,2024-11-02 03:46:00 GMT,01-Nov-2024 23:46,,,,,,,Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0518,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-02-12,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 11:59:01 UTC,,2025-05-06 12:00:08 UTC,false,,1,2025-05-06 12:00:08 UTC,2025-08-19 10:50:11 UTC,0,0,2025-03-05 10:10:00 EST,2025-03-05 15:10:00 UTC,2025-03-05 15:10:00 GMT,05-Mar-2025 10:10,2025-03-06 10:15:00 EST,2025-03-06 15:15:00 UTC,2025-03-06 15:15:00 GMT,06-Mar-2025 10:15,500,mg,5,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0532,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-13,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 18:01:10 UTC,,2025-05-06 18:01:47 UTC,false,,1,2025-05-06 18:01:47 UTC,2025-08-19 10:50:11 UTC,0,0,2025-04-09 11:11:00 EDT,2025-04-09 15:11:00 UTC,2025-04-09 15:11:00 GMT,09-Apr-2025 11:11,2025-04-10 11:20:00 EDT,2025-04-10 15:20:00 UTC,2025-04-10 15:20:00 GMT,10-Apr-2025 11:20,500,mg,23,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0520,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-02-05,2,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-06 12:04:54 UTC,,2025-05-06 12:06:17 UTC,true,Form not done,1,2025-05-06 12:06:18 UTC,2025-08-19 10:50:11 UTC,0,0,,,,,,,,,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0520,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-02-05,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 11:57:55 UTC,,2025-05-06 11:58:38 UTC,false,,1,2025-05-06 11:58:37 UTC,2025-08-19 10:50:11 UTC,0,0,2025-03-05 10:10:00 EST,2025-03-05 15:10:00 UTC,2025-03-05 15:10:00 GMT,05-Mar-2025 10:10,2025-03-06 10:15:00 EST,2025-03-06 15:15:00 UTC,2025-03-06 15:15:00 GMT,06-Mar-2025 10:15,500,mg,-5,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0532,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-13,2,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-06 18:02:13 UTC,,2025-05-06 18:03:05 UTC,false,,1,2025-05-06 18:03:00 UTC,2025-08-19 10:50:11 UTC,1,0,2025-04-16 12:12:00 EDT,2025-04-16 16:12:00 UTC,2025-04-16 16:12:00 GMT,16-Apr-2025 12:12,2025-04-17 12:15:00 EDT,2025-04-17 16:15:00 UTC,2025-04-17 16:15:00 GMT,17-Apr-2025 12:15,500,mg,55,mg,Intravenous,EVERY FOUR WEEKS,Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0591,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-12 06:50:09 UTC,,2025-05-12 06:50:32 UTC,false,,1,2025-05-12 06:50:31 UTC,2025-08-19 10:50:11 UTC,0,0,2025-05-08 12:00:00 EDT,2025-05-08 16:00:00 UTC,2025-05-08 16:00:00 GMT,08-May-2025 12:00,2025-05-10 13:00:00 EDT,2025-05-10 17:00:00 UTC,2025-05-10 17:00:00 GMT,10-May-2025 13:00,500,mg,20,mg,Intravenous,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999998,SCR-0108,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2005-04-01,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-08-08 19:52:22 UTC,,2025-08-08 19:52:24 UTC,false,,1,2025-08-08 19:52:22 UTC,2025-08-19 10:50:11 UTC,7,0,2025-02-08 11:11:00 EST,2025-02-08 16:11:00 UTC,2025-02-08 16:11:00 GMT,08-Feb-2025 11:11,,,,,,,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0508,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 09:38:05 UTC,,2025-05-06 09:38:41 UTC,false,,1,2025-05-06 09:38:40 UTC,2025-08-19 10:50:11 UTC,0,0,2025-05-01 12:00:00 EDT,2025-05-01 16:00:00 UTC,2025-05-01 16:00:00 GMT,01-May-2025 12:00,2025-05-05 13:00:00 EDT,2025-05-05 17:00:00 UTC,2025-05-05 17:00:00 GMT,05-May-2025 13:00,500,mg,300,mg,Intravenous,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0533,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-06,2,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-06 18:07:15 UTC,,2025-05-06 18:08:00 UTC,false,,1,2025-05-06 18:07:59 UTC,2025-08-19 10:50:11 UTC,0,0,2025-04-09 11:15:00 EDT,2025-04-09 15:15:00 UTC,2025-04-09 15:15:00 GMT,09-Apr-2025 11:15,2025-04-10 11:16:00 EDT,2025-04-10 15:16:00 UTC,2025-04-10 15:16:00 GMT,10-Apr-2025 11:16,500,mg,25,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0600,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-21 09:33:10 UTC,,2025-05-21 09:33:27 UTC,false,,1,2025-05-21 09:33:26 UTC,2025-08-19 10:50:11 UTC,2,0,2025-05-02 12:00:00 EDT,2025-05-02 16:00:00 UTC,2025-05-02 16:00:00 GMT,02-May-2025 12:00,2025-05-03 13:00:00 EDT,2025-05-03 17:00:00 UTC,2025-05-03 17:00:00 GMT,03-May-2025 13:00,500,mg,,mg,Intravenous,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0496,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 07:18:29 UTC,,2025-05-06 07:18:50 UTC,false,,1,2025-05-06 07:18:49 UTC,2025-08-19 10:50:11 UTC,1,0,2025-05-01 12:00:00 EDT,2025-05-01 16:00:00 UTC,2025-05-01 16:00:00 GMT,01-May-2025 12:00,2025-05-02 13:00:00 EDT,2025-05-02 17:00:00 UTC,2025-05-02 17:00:00 GMT,02-May-2025 13:00,500,mg,250,mg,Intravenous,EVERY FOUR WEEKS,Adverse event,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0601,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2023-02-05,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-21 09:41:27 UTC,,2025-05-21 09:42:21 UTC,false,,1,2025-05-21 09:42:20 UTC,2025-08-19 10:50:11 UTC,4,0,2025-05-01 12:00:00 EDT,2025-05-01 16:00:00 UTC,2025-05-01 16:00:00 GMT,01-May-2025 12:00,2025-05-01 13:00:00 EDT,2025-05-01 17:00:00 UTC,2025-05-01 17:00:00 GMT,01-May-2025 13:00,500,mg,,,,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0533,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-06,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-06 18:04:08 UTC,,2025-05-06 18:05:00 UTC,false,,1,2025-05-06 18:05:00 UTC,2025-08-19 10:50:11 UTC,0,0,2025-04-09 11:15:00 EDT,2025-04-09 15:15:00 UTC,2025-04-09 15:15:00 GMT,09-Apr-2025 11:15,2025-04-10 11:16:00 EDT,2025-04-10 15:16:00 UTC,2025-04-10 15:16:00 GMT,10-Apr-2025 11:16,500,mg,25,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0560,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-13,2,Study Treatment Administration - Budigalimab,EC_F_1,2,Submitted,2025-05-08 08:17:33 UTC,,2025-05-08 08:18:17 UTC,false,,1,2025-05-08 08:18:17 UTC,2025-08-19 10:50:11 UTC,0,0,2025-04-11 10:20:00 EDT,2025-04-11 14:20:00 UTC,2025-04-11 14:20:00 GMT,11-Apr-2025 10:20,2025-04-12 10:30:00 EDT,2025-04-12 14:30:00 UTC,2025-04-12 14:30:00 GMT,12-Apr-2025 10:30,500,mg,55,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0560,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-03-13,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-08 08:15:31 UTC,,2025-05-08 08:16:37 UTC,false,,1,2025-05-08 08:16:37 UTC,2025-08-19 10:50:11 UTC,0,0,2025-04-10 10:10:00 EDT,2025-04-10 14:10:00 UTC,2025-04-10 14:10:00 GMT,10-Apr-2025 10:10,2025-04-13 10:15:00 EDT,2025-04-13 14:15:00 UTC,2025-04-13 14:15:00 GMT,13-Apr-2025 10:15,500,mg,55,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0572,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2019-05-10,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-08 13:58:36 UTC,,2025-05-08 14:01:08 UTC,false,,1,2025-05-08 14:01:07 UTC,2025-08-19 10:50:11 UTC,0,0,2020-09-08 12:30:00 EDT,2020-09-08 16:30:00 UTC,2020-09-08 16:30:00 GMT,08-Sep-2020 12:30,2020-09-09 12:30:00 EDT,2020-09-09 16:30:00 UTC,2020-09-09 16:30:00 GMT,09-Sep-2020 12:30,500,mg,1AAAAAAAA1,mg,Intravenous,EVERY FOUR WEEKS,Physician decision based on risk/benefit assessment,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0595,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-12 07:11:54 UTC,,2025-05-12 07:12:20 UTC,false,,1,2025-05-12 07:12:13 UTC,2025-08-19 10:50:11 UTC,0,0,2025-05-02 13:00:00 EDT,2025-05-02 17:00:00 UTC,2025-05-02 17:00:00 GMT,02-May-2025 13:00,2025-05-03 14:00:00 EDT,2025-05-03 18:00:00 UTC,2025-05-03 18:00:00 GMT,03-May-2025 14:00,500,mg,250,mg,Intravenous,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0580,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-09 08:38:30 UTC,,2025-05-09 15:14:38 UTC,false,,1,2025-05-09 15:14:36 UTC,2025-08-19 10:50:11 UTC,0,7,2025-05-06 12:12:00 EDT,2025-05-06 16:12:00 UTC,2025-05-06 16:12:00 GMT,06-May-2025 12:12,2025-05-07 12:12:00 EDT,2025-05-07 16:12:00 UTC,2025-05-07 16:12:00 GMT,07-May-2025 12:12,500,mg,23,mg,Intravenous,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0604,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-15 12:32:41 UTC,,2025-05-15 12:32:49 UTC,false,,1,2025-05-15 12:32:48 UTC,2025-08-19 10:50:11 UTC,4,0,2025-05-14 12:00:00 EDT,2025-05-14 16:00:00 UTC,2025-05-14 16:00:00 GMT,14-May-2025 12:00,,,,,500,mg,,,Intravenous,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0581,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-09 08:43:53 UTC,,2025-05-09 08:44:11 UTC,false,,1,2025-05-09 08:44:11 UTC,2025-08-19 10:50:11 UTC,5,0,2025-05-02 12:12:00 EDT,2025-05-02 16:12:00 UTC,2025-05-02 16:12:00 GMT,02-May-2025 12:12,2025-05-03 12:12:00 EDT,2025-05-03 16:12:00 UTC,2025-05-03 16:12:00 GMT,03-May-2025 12:12,,,,,,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0608,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-03,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-20 01:12:25 UTC,,2025-05-20 01:12:40 UTC,false,,1,2025-05-20 01:12:40 UTC,2025-08-19 10:50:11 UTC,4,0,2025-04-03 12:00:00 EDT,2025-04-03 16:00:00 UTC,2025-04-03 16:00:00 GMT,03-Apr-2025 12:00,2025-04-16 13:00:00 EDT,2025-04-16 17:00:00 UTC,2025-04-16 17:00:00 GMT,16-Apr-2025 13:00,500,,,,Intravenous,,,No,,No,,No,,No,,No,
M24-977_TST1,United States,9999999,SCR-0597,Cycle (1),eg_CYCLE,1,Day 1,ev_DAY1,2025-05-04,2,Study Treatment Administration - Budigalimab,EC_F_1,1,Submitted,2025-05-12 07:41:04 UTC,,2025-05-12 07:41:23 UTC,false,,1,2025-05-12 07:41:22 UTC,2025-08-19 10:50:11 UTC,0,0,2025-05-02 12:00:00 EDT,2025-05-02 16:00:00 UTC,2025-05-02 16:00:00 GMT,02-May-2025 12:00,2025-05-03 12:00:00 EDT,2025-05-03 16:00:00 UTC,2025-05-03 16:00:00 GMT,03-May-2025 12:00,500,mg,250,mg,Intravenous,EVERY FOUR WEEKS,,No,,No,,No,,No,,No,
